C-Reveal Therapeutics
C-Reveal’s proprietary technology helps the body’s natural immune system to identify and kill cancer cells.
Analytics
Raised to Date: $710,470
Aggregate Commitments $
Netcapital
01/28/2021
04/16/2021
$10,000
$1,070,000
$100
Equity - Common
RegCF / RegD 506(C)
Pre-Seed
$10,000,000
Weekly Commitments $
Active
02/24/2021
50
7,105%
66%
$26,314
Pembroke, Massachusetts
Healthcare & Pharmaceuticals
HealthTech
B2B
High
High
C-Reveal Therapeutics, with a post-money valuation of $13.25 million, is raising crowdfunding on NetCapital. The company has identified two key cancer-specific enzymes that, when inhibited, reveal hidden tumors to the immune system. C-Reveal plans to develop inhibitors for these enzymes, which will enable the immune system to recognize, target, and attack cancer cells. They will also allow existing cancer immunotherapies to work in a greater number of patients. The company was founded by Thomas Haag, Ph.D., J.D., Mark Cobbold, M.D., Ph.D., Keith Flaherty, M.D., and Cyril Benes, Ph.D. The current round of crowdfunding has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used for new patents, R&D, hiring, marketing, and operating expenses. C-Reveal is partnering with Evotec, a European-based contract research organization, for the next step in our drug discovery process.
Summary of Crowdfunding Raises
| Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/16/2021 | Netcapital | $10,000,000 | $710,470 | Equity - Common | Active | RegCF |
| 01/27/2021 | Netcapital | $10,000,000 | $0 | Equity - Common | Confirmed Closed | Test the Waters |
Ratings
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Analyst Report
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals
MedVector on StartEngine
The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that
Phoenix PharmaLabs on Netcapital
In the years before the world’s current COVID-19 crisis, America in particular faced a deadly and persistent threat…
Millennial Fertility Co. on NetCapital
The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…